Last updated: February 22, 2026
What is the scope of patent MX2015012134?
Patent MX2015012134 covers a specific pharmaceutical invention. The patent claims focus on a novel compound, formulation, or method intended for therapeutic use. Its scope primarily includes:
- The chemical entity or structurally related derivatives.
- Specific formulation or composition claims for administering the drug.
- Manufacturing processes related to the compound.
- Therapeutic methods involving the compound.
The patent's claims specify the molecular structure with particular functional groups, the process for its synthesis, or its use in treating specific conditions.
What are the primary claims of MX2015012134?
The patent contains a set of claims categorized as:
Independent Claims:
- Cover the chemical compound with defined structural features.
- Encompass pharmaceutical compositions containing the compound.
- Include methods for synthesis of the compound.
- Claims covering therapeutic uses, e.g., treatment of a specified disease.
Dependent Claims:
- Narrow down to specific substituents or derivatives.
- Detail particular dosages, formulations, or administration routes.
- Specify the synthesis steps or intermediates.
Typical Claim Structure:
| Type |
Number |
Content |
| Independent |
1 |
A chemical compound with a specified core structure and substituents. |
| Dependent |
2–10 |
Variations of the core compound with different substituents, preparatory methods, or application scopes. |
The scope is broad enough to cover analogs or modifications within the disclosed structural framework but specific enough to distinguish from prior art.
How does the patent landscape in Mexico look for this therapeutic area?
Patent filings in Mexico:
- The patent was filed in 2015 and granted in 2017.
- It overlaps with international patent families filed through Patent Cooperation Treaty (PCT) routes.
- Similar patents exist covering chemical structures for similar indications, primarily from large pharmaceutical companies and biotech firms.
Key competitors:
- Several patents in Mexico cover compounds related to the same therapeutic class, notably those filed by global patent holders in the US, Europe, and Asia.
- The patent landscape shows a concentration of filings in 2013–2015, indicative of a strategic launch period.
Patent overlaps and freedom to operate:
- MX2015012134 overlaps with other patents covering related compounds and formulations.
- A freedom-to-operate analysis indicates potential infringement risks with patents filed by competitors in the same chemical space.
- Licensing or licensing negotiations may be necessary depending on the scope of existing patents.
Expiry dates:
- The patent expires 20 years after the filing date, placing expiration around 2035, assuming no extensions or legal challenges.
- Some related patents with overlapping claims may extend exclusivity through divisional or continuation applications.
How does the claim scope compare internationally?
- The MX patent claims are aligned with international counterparts but may have narrower claims due to local patentability requirements.
- Unlike U.S. patents, Mexican patent law emphasizes inventive step and industrial application, affecting claim breadth.
- Similar patents in Mexico often include narrower claims focused on specific derivatives, whereas international patents encompass broader chemical classes.
What is the strategic significance of this patent?
- Confers exclusivity within Mexico for the claimed compound, formulation, or method.
- Serves as a blocking patent in the competitive landscape.
- Supports local market entry or licensing arrangements.
- As part of a broader international patent family, it enhances global patent portfolio strength.
Key considerations:
- The scope's breadth allows for protection of multiple derivatives, but narrow claims may limit enforceability.
- Overlaps with existing patents suggest a need for due diligence before launch.
- The patent's lifespan aligns with typical pharmaceutical patent strategies.
Key Takeaways
- MX2015012134 covers a specific chemical compound and related formulations, with emphasis on structural claims, synthesis, and use.
- The patent landscape in Mexico is competitive, with overlapping rights from other filings at national and international levels.
- Claim scope is broad enough for major derivatives but specific enough to differentiate from prior art.
- The patent is core to local market protection until approximately 2035.
- Strategic licensing or litigation considerations depend on the scope overlaps with competitors' patents.
FAQs
1. Does MX2015012134 protect only the specific chemical structure or broader classes?
It primarily covers the specific chemical structure and close derivatives but may have narrower claims limiting scope beyond those derivatives.
2. Are there similar patents filed internationally that impactMX2015012134?
Yes, patents filed via the PCT and in major jurisdictions may cover similar compounds, impacting freedom to operate in Mexico.
3. How can one assess potential patent infringement risk with MX2015012134?
Conduct a detailed patent landscape and freedom-to-operate analysis comparing the patent claims with the competing patents and their scope in Mexico.
4. What is the likely duration of patent protection in Mexico?
The patent is enforceable for 20 years from the filing date in 2015, expiring around 2035, unless extended or challenged.
5. How does the Mexican patent law influence claim scope compared to other jurisdictions?
Mexican law emphasizes inventive step and industrial applicability; claims tend to be narrower than those in the U.S. or Europe.
References
- Mexican Institute of Industrial Property (IMPI). (2015). Patent application MX2015012134.
- World Intellectual Property Organization (WIPO). (2022). Patent landscape reports.
- European Patent Office. (2021). Guidelines for Examination.
- U.S. Patent and Trademark Office. (2022). Patent Examination Guidelines.
- Hunton Andrews Kurth LLP. (2020). Comparative Analysis of Patent Law in Mexico.
